Zobrazeno 1 - 10 of 3 077 pro vyhledávání: '"Livasy CA"'
1
Akademický článek
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
Autor: Burgess EF; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC. Electronic address: earle.burgess@atriumhealth.org., Livasy CA; Department of Pathology, Atrium Health, Levine Cancer Institute, Charlotte, NC., Symanowski JT; Department of Biostatistics and Data Sciences, Atrium Health, Levine Cancer Institute, Charlotte, NC., Matulay JT; Department of Urology, Atrium Health, Charlotte, NC., Grigg CM; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC., Clark PE; Department of Urology, Atrium Health, Charlotte, NC., Raghavan D; Department of Solid Tumor Oncology, Atrium Health, Levine Cancer Institute; Charlotte, NC.
Publikováno v: Urologic oncology [Urol Oncol] 2023 Aug; Vol. 41 (8), pp. 357.e23-357.e29. Date of Electronic Publication: 2023 Jun 07.
Zobrazit plný text záznamu
2
Akademický článek
Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
Autor: Elder EA; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Livasy CA; Department of Pathology, Levine Cancer Institute, Charlotte, NC, USA., Donahue EE; Department of Cancer Biostatistics, Levine Cancer Institute, Charlotte, NC, USA., Neelands B; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA., Patrick A; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA., Needham M; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA.; Clinical Trials Department, Levine Cancer Institute, Charlotte, NC, USA., Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Heeke AL; Department of Medical Oncology, Levine Cancer Institute, Charlotte, NC, USA., White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA. richard.white@atriumhealth.org.
Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8060-8069. Date of Electronic Publication: 2022 Aug 18.
Zobrazit plný text záznamu
3
Akademický článek
Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?
Autor: Pestana CV; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Livasy CA; Department of Pathology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Donahue EE; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Neelands B; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Tan AR; Department of Solid Tumor and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Richard.white@atriumhealth.org.
Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2022 Nov; Vol. 29 (12), pp. 7716-7724. Date of Electronic Publication: 2022 Jul 09.
Zobrazit plný text záznamu
4
Akademický článek
Investigating the clinical significance of OAS family genes in breast cancer: an in vitro and in silico study.
Autor: Lu, Jinjun1 (AUTHOR) lujinjun1982137@sina.com, Yang, Lu2 (AUTHOR) dandelion_123456@sina.com, Yang, Xinghai1 (AUTHOR) xinghaiyang2024@sina.com, Chen, Bin1 (AUTHOR) chenbin9327@sina.com, Liu, Zheqi3 (AUTHOR) liuzheqi202406@outlook.com
Publikováno v: Hereditas. 12/5/2024, Vol. 161 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
6
Akademický článek
Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
Autor: Phantana-Angkool A; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Voci AE; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Warren YE; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Livasy CA; Charlotte Pathology Group, Charlotte, NC, USA., Beasley LM; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Robinson MM; Department of Cancer Biostatistics, Levine Cancer Institute, Charlotte, NC, USA., Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Forster MR; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Sarma D; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA. Richard.White@carolinashealthcare.org.
Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2019 Nov; Vol. 26 (12), pp. 3874-3882. Date of Electronic Publication: 2019 Jul 24.
Zobrazit plný text záznamu
7
Akademický článek
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
Autor: Norris EJ; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Zhang Q; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Jones WD; Department of Bioinformatics and Clinical Systems, Q2 Solutions - EA Genomics, Morrisville, NC, USA., DeStephanis D; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Sutker AP; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Livasy CA; Carolinas Pathology Group, Charlotte, NC, USA., Ganapathi RN; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Tait DL; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Ganapathi MK; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Publikováno v: The Journal of pathology [J Pathol] 2019 Jul; Vol. 248 (3), pp. 352-362. Date of Electronic Publication: 2019 May 14.
Zobrazit plný text záznamu
8
Akademický článek
Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis.
Autor: Phantana-Angkool A; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Forster MR; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Warren YE; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Livasy CA; Charlotte Pathology Group, Charlotte, NC, USA., Sobel AH; Charlotte Radiology, Charlotte, NC, USA., Beasley LM; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Trufan SJ; Department of Cancer Biostatistics, Levine Cancer Institute, Charlotte, NC, USA., Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Voci AE; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., Sarma D; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA., White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC, USA. richard.white@atriumhealth.org.; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, 1021 Morehead Medical Drive Suite 6200, Charlotte, NC, 28204, USA. richard.white@atriumhealth.org.
Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Jan; Vol. 173 (1), pp. 23-29. Date of Electronic Publication: 2018 Sep 21.
Zobrazit plný text záznamu
9
Akademický článek
Breast cancer metastatic to the liver with hepatoid features and hepatocyte paraffin 1 positivity mimicking hepatocellular carcinoma.
Autor: Affleck A; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA., Lyman WB; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA., Jacobs C; Department of Pathology, Carolinas Medical Center, Charlotte, NC, USA., Livasy CA; Department of Pathology, Carolinas Medical Center, Charlotte, NC, USA., Martinie JB; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA., Iannitti DA; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA., Vrochides D; Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC, USA.
Publikováno v: Histopathology [Histopathology] 2018 Sep; Vol. 73 (3), pp. 529-531. Date of Electronic Publication: 2018 Jun 22.
Zobrazit plný text záznamu
10
Akademický článek
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Autor: Miller KR; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Patel JN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Zhang Q; Department of Biostatistics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Norris EJ; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Symanowski J; Department of Biostatistics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Michener C; Women's Health and Obstetrics/Gynecology Institute, Cleveland Clinic, Cleveland, OH, USA., Sehouli J; Department of Gynecology, Charité Medical University of Berlin, Berlin, Germany., Braicu I; Department of Gynecology, Charité Medical University of Berlin, Berlin, Germany., Destephanis DD; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Sutker AP; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA., Jones W; Bioinformatics and Clinical Systems, Q(2) Solutions - EA Genomics, 5927 S. Miami Blvd., Suite 100, Morrisville, NC 27560, USA., Livasy CA; Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, NC, USA., Biscotti C; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA., Ganapathi RN; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. Electronic address: ram.ganapathi@carolinashealthcare.org., Tait DL; Division of Gynecologic Oncology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC 28204, USA. Electronic address: david.tait@carolinashealthcare.org., Ganapathi MK; Department of Cancer Pharmacology, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA. Electronic address: mahrukh.ganapathi@carolinashealthcare.org.
Publikováno v: Gynecologic oncology [Gynecol Oncol] 2018 Apr; Vol. 149 (1), pp. 155-162.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje